Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Explore work from home jobs that pay well, providing you the opportunity to earn a great income while enjoying the comfort of home.
19,883 articlesAs biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Federal economists say tariffs are unlikely to be a one-off hit. Instead, a trump created ‘trickle up’ pricing approa...
Wall Street is piling into hydration brands as 'functional hydration' takes hold. The trend follows social media chat...
Figma’s shares surged 11.9% in trading today, but without a flashy headline to explain the move. The action hints at ...
Joe Biden’s forthcoming memoir, Promise Me, America, lands November 17, two weeks after the midterms. The release cou...
A prominent personal-finance voice argues the single most valuable retirement gift is the way a couple times Social S...
A single director's sale at MannKind raises questions about the durability of royalty streams. This analysis breaks d...
A great-looking loan deal can hide serious risks. Discover seven red flags and proven strategies to protect your mone...
February can test nerves, but smart stock selection pays off. Here are two robust candidates that align with the curr...
KBR faced a two-sided story: a massive backlog that hints at strong future demand, and a prominent investor trimming ...
A looming court decision and budget pressures place the consumer financial protection bureau at a crossroads, with co...
D-Wave QBTS delivered a notable Q4 2025 run, with rising revenue and expanding services. This story breaks down what ...